Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Riccardi

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Breast Cancer Research and Treatment|August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian studyM Campiglio, R Bufalino, M Sasso, et al.
International Journal of Oncology|September 2, 2014
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III studyV Lorusso, F Giotta, R Bordonaro, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Neuroendocrine tumors diagnosed at the Antonio Cardarelli hospital (Naples, Italy) between 2006-2009: a single-institution analysisF Riccardi, O Nappi, A Balzano, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Scientific Reports|July 28, 2023
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB Trevisan, F F Pepe, I Vallini, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Breast Cancer Research and Treatment|August 15, 2013
Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian studyM Campiglio, R Bufalino, M Sasso, et al.
International Journal of Oncology|September 2, 2014
Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy:a multicenter phase III studyV Lorusso, F Giotta, R Bordonaro, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Neuroendocrine tumors diagnosed at the Antonio Cardarelli hospital (Naples, Italy) between 2006-2009: a single-institution analysisF Riccardi, O Nappi, A Balzano, et al.
ESMO Open|April 5, 2021
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational studyF Schettini, B Conte, G Buono, et al.
ESMO Open|January 4, 2025
Ten-year update of HOBOE phase III trial comparing triptorelin plus either tamoxifen or letrozole or zoledronic acid + letrozole in premenopausal hormone receptor-positive early breast cancer patientsA Gravina, P Gargiulo, M De Laurentiis, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 21, 2019
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective studyE Gobbini, R Chiari, P Pizzutillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trialF Perrone, F Nuzzo, F Di Rella, et al.
Breast (Edinburgh, Scotland)|August 31, 2019
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 studyM E Cazzaniga, G Pinotti, E Montagna, et al.
Scientific Reports|July 28, 2023
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patientsB Trevisan, F F Pepe, I Vallini, et al.
Breast Cancer Research and Treatment|September 21, 2021
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 studyM E Cazzaniga, I Vallini, E Montagna, et al.
Pageof 6